Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:1248-1252
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, J. L.
Right arrow Articles by Hart, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, J. L.
Right arrow Articles by Hart, N.

A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease

Jeffrey L. Anderson, MD, FACCa, Jessica Habashi, BSa, John F. Carlquist, PhDa, Joseph B. Muhlestein, MD, FACCa, Benjamin D. Horne, MPHa, Tami L. Bair, BSa, Robert R. Pearson, BSa and Noal Hart, BSa

a University of Utah, LDS Hospital, Salt Lake City, Utah, USA



View larger version (14K):

[in a new window]
 
Figure 1 Kaplan-Meier survival-time plot for cardiovascular death by AMPD1 genotype (wild type vs. variant heterozygote or homozygote). There are four events (4.4%) among 90 patients carrying the mutant polymorphism and 33 events (11.9%) among noncarriers, a statistically significant difference (log-rank statistic 4.0, p = 0.046; Breslow statistic 4.1, p = 0.043). Solid line = AMPD1(–) variant carrier; dotted line = variant noncarrier.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement